We have explored Oct4-positive cells residing in the human amniotic membrane (HAM) at various stages of gestation. Here, we report that a number of Oct4-positive human amniotic epithelial (HAE) cells can be recovered as potentially pluripotent stem cells from any stage of human embryonic development. We found that Oct4-expressing cell subsets are clustered in specific regions of the human amniotic epithelium. Immunohistochemical examination suggests the expression levels of Oct4 protein vary at the single cell level in these cohorts as well as in vitro. These Oct4-positive HAE cells can be harvested and enriched in vitro as a potential source of pluripotent somatic stem cells under defined culture conditions. These cultured HAE cells expressed several marker genes for undifferentiated human embryonic stem (huES) cell lines that included connexins (hCx43 and hCx45), Pro-Galanin, Nanog, ABCG2 and hRex1. Several differentiation markers were also detected, such as nestin as a marker for neuroectodermal progenitor cells, albumin and amylase of hepatic cell type, and CK19 as an epithelial cell marker, as determined by RT-PCR and immunocytochemical analysis. Moreover, chromogranin A and glut2, marker genes for neuroendocrine pancreatic cells, were shown to be inducible at the mRNA level in response to glucose and nicotinamide. These results further strengthen the notion that the human amniotic epithelium provides an unlimited promising source of potentially useful hES-like somatic cells that possess multiple differentiation potential to give rise to a functionally different wide variety of cell types.
INTRODUCTION
Oct4 is a POU Domain containing octamer -binding transcriptional regulatory factor that is differentially expressed in early embryonic cells [1] [2] [3] . Pluripotent embryonic stem (ES) cell lines that possess indefinite proliferative capacity can be established from the Oct4-positive undifferentiated inner cell mass (ICM) in blastocysts [4] [5] [6] . The expression level of Oct4 protein has been demonstrated to be a critical factor for the fate determination of embryonic cells, including ES cells in vitro, which give rise to various cell types [7] [8] [9] . When its expression is downregulated, Oct4-negative cells differentiate to almost all somatic cell lineage [9] [10] [11] and the expression of Oct4 is restricted to primordial germ cells during embryonic development [3, 7, 8, [12] [13] [14] . Thus, Oct4 protein has become a widely accepted specific marker molecule for cells that possess pluripotency [5, 11, 14] . Taking into account the properties exhibited by Oct4-positive embryonic cells, manipulation of human blastocysts has been eagerly claimed as a means to establish ES cell lines for use in biomedical applications [5, 15, 16] ; however the manipulation of human embryos for the sake of ES cell research is still controversial and under strict regulation in many nations.
More recently, it was demonstrated that an Oct4-expressing cell subset is present within amniotic fluid [17] , in which various cell types of different embryonic / fetal origin from all three germ layers, including the amniotic membrane, have been identified [18] [19] [20] [21] . These observations raise the possibility that pluripotent somatic stem cells reside within the *Address correspondence to this author at the Laboratory of Molecular Cell Biology and Oncology, Kanagawa Cancer Center Research Institute 241-0815 Nakao, Asahi-ku, Yokohama, Japan; E-mails: kxkbk831@ybb.ne.jp, yasumoto@gancen.asahi.yokohama.jp amniotic membrane, as well as in developing embryonic tissues. In these studies, however, the recovery of Oct4-positive cells from amniotic fluid was inefficient (fewer than 0.1 -0.5% of recovered human amniotic fluid cells) [17] , with the exact origin and biological capabilities of the various cell types found in the amniotic fluid not precisely known as yet.
Here, we have explored a resident Oct4-expressing cell subset in human embryonic tissues and demonstrate that Oct4-positive cells are present at a specific location in HAM. We have characterized these Oct4-expressing HAE cells in vitro and found that they possess self-amplifying potentials.
Gene expression profiles also demonstrate the presence of several undifferentiated cell markers associated with human ES cell lines [22] as well as of multiple differentiation markers for neuroectodermal and neuroendodermal cell types. These results may provide a basis for an unlimited source of putatively pluripotent stem cells from HAM of newborns with fewer ethical barriers.
RESULTS

Oct-4 Expressing Cell Subset in Human Amniotic Epithelial Cells
Immunohistochemistry was used to identify a resident Oct4-positive cell subset within HAM obtained at full-term (40 weeks' gestation) delivery. A number of Oct4-positive cells were found to reside within a specific region of the HAE layer around the placenta, termed the stem cell niche (SCN), in which a cluster of HAE cells was found expressing Oct4 at various levels and Oct4-negative cells (Fig. 1A) . The varied expression levels of Oct4-protein were analyzed by software to measure pixel intensities of the DAB stain per cell indicative of strong (s), moderate (m), weak (w) and negative (n) within the overall collection of Oct4-positive cells (Fig. 1A a -c) . These Oct4-positive cell subsets were distributed across the HAE layer, but were rarely found in far-distal regions of the SCN (data not shown).
This raises the intriguing possibility that the pluripotent Oct4-expressing stem cell subset may be isolated from the human amnion with a high degree of efficiency, with consequently fewer problems as compared to the generation of equivalent cells from the ICM of developing human embryos.
Oct4-Positive HAE Cells can be Propagated In Vitro
To investigate the characteristics of Oct4-positive HAE cells, we firstly attempted to recover HAE cells from amniotic tissue specimens obtained after full -term derivery (av.40 wgestation) and to grow them in vitro. We utilized a mixtur of two media types (DMEM and Ham's MCDB153 with supplements, details in Methods section) to facilitate the growth in vitro; this permitted expansion of HAE cells over a 6 w period (Fig. 1B) . Our culture media mixture effectively supported the growth of HAE cells in contrast to conven- Fig. (1) . Oct4-positive cell subsets detected in the HAE layer and within its cultured HAE cell population derived from full-term (40 weeks) delivery. All specimens were briefly counter-stained with hematoxylin unless otherwise indicated. A) Immunohistochemically detected Oct4-positive cell subsets (brownish colour) are clustered at a local HAE layer around the placenta, termed SCN. Bar indicates 100 μm. (Fig.1C) . Moreover, we noticed that the expression level of Oct4-protein varied within individual Oct4-posirive cells, as noted previously among HAE layer. They were similarly recognized as Oct4-positive cells that were expressed stronger (s), moderately (m)and weakly(w) (Fig.1C, arrows) .
To follow the fate of Oct4-positive cells in serial cultivation in vitro, the cultured HAE cells were immunostained with anti-Oct4 at the end of each passage when the cells became confuent. We found that Oct4-positive cells persistently remained in the serial cultivation in vitro. Moreover, Oct4-positive HAE cells appeared to clonally grow and form micro-colonies consisting of Oct4-positive cells among the Oct4-negative cells, strongly suggesting that Oct4-positive HAE cells are capable of self-amplifying to some extent under these culture conditions (Fig. 1D) . When 12 microcolonies, consisting of more than seven Oct4-positive cells, were randomly selected and the number of Oct4-positive cells at the time of each passage was averaged (primary to tertiary) (Fig. 1E) . These results may allow us to roughly estimate the division potential as about once a few days, indicating that Oct4-expressing HAE cells maintained their division potentials throughout serial cultivation, at least up to a month.
Oct4-Expressing HAE Cells in the Earlier Stages of Human Fetus Development
We next examined whether Oct4-expressing cells could similarly reside within the amniotic membrane in earlier fetus development. Immunohistochemistry of HAM at 16 -18 w gestation, clearly showed that Oct4-positive cells existed within the HAE layer where Oct4-positive cells were rather uniformly distributed over the HAE layer ( Fig. 2A) . The HAE cells recovered from these specimens actively grew under our culture conditions. Immunocytochemistry again identified an Oct4-positive HAE cell cohort within the Oct4-negative HAE cell population (Fig. 2B) . Moreover, the finding of mitotic figures of Oct4-positive cells directly shows that Oct4-expressing HAE cells possess division potentials in vitro (Fig. C, arrow) . Notably, post-mitotic nuclei were both equally Oct4-positive, strongly suggesting that Oct4-expressing HAE cells possess self-renewing activity with respect to the Oct4 expression that results in the amplification of Oct4-positive stem cells.
Proliferation Potentials and Stemness-Related Gene Expression
When the cell growth of 18 -w HAE cells was compared with that of 40 -w HAE cells, the HAE cells obtained from the earlier embryonic stage exhibited superior multiplication potential ( Fig. 2D ) and contained more Oct4-positive cells in the culture (Fig. 2E) .
However, the number of Oct4-positive cells decreased to some extents during serial cultivation (data not shown), with the proportion of Oct4-negative cells accumulating within the growing HAE cell population over time, which may be attributable to the onset of differentiation in vitro.
To know whether gene expression profiles would change in HAE cells derived from different ages, 18 w versus 40 w, of amnion, a unique set of marker genes that is associated with undifferentiated human ES cells was examined by RT-PCR using the published primer sets (see MATERIALS and METHODS). We detected mRNAs of several genes that have been identified within certain human ES cell lines [22] . These included connexins (hCx43, hCx45), Pro-Galanin, Nanog, ABCG2 and hRex1 (Fig. 2F) . While, hUTF, Dppa5, GDF3 and hTERT were undetecteble at mRNA level (data not shown). These results demonstrate that HAE cells contain undifferentiated and potentially pluripotent stem cells throughout human fetus development.
Marker Genes Relevant to Multiple Differentiation Potentials of HAE Cells
To characterize differentiated HAE cells in vitro, the expression of several cell-specific differentiation markers were examined at the mRNA level, with transcript for nestin, albumin, CK19 and Oct4 being assessed by RT-PCR analysis (Fig. 3A) . These results suggest that the cultured HAE cells became constituted of heterogeneous cell subsets, as a result of differentiation to nerve cells or hepatocytes in vitro. Nestin mRNA was only present at a low abundance; moreover, the level of nestin mRNA remain unchanged in HAE cells at different developmental stages, i.e. 16 w versus 40 w gestation. It is consistent with the observation that only a few percent of nestin-positive cells were shown by immunocytochemistry (Fig. 3B a) . In contrast, the expression levels of Oct4 mRNA in HAE cells from 16 w HAE layer were several fold higher than that found in 40 w samples, probably reflecting differences in the number of Oct4-expressing cells within the HAE cell population (refer to Fig. 2) . Immunofluorescent staining also identified an albumin-producing cell subset (Fig. 3B, b) , suggesting the presence of hepatic cells. Confocal laser immunofluorescent microscopy further demonstrated that the albumin-positive cells also co-expressed cytokeratin 19 (CK19), which is a marker protein for epithelial cells including bile ductal epithelial cells (Fig. 3B.  b, c, d ).
Specific Cell Markers for Neuroendocline Cells
To test for other differentiation markers, we attempted to identify pancreatic cell-specific gene expression. However, neither insulin nor glucagon was detected, thus providing no evidence for terminally differentiated pancreatic cells and cells under the present culture system (data not shown). Instead, we detected the expression of CgA and glut2, which are also markers for neuroendocrin cells (Fig. 3C) . These latter two genes were detected after being induced with higher concentrations of glucose in the presence of nicotinamide. Moreover, the augmented expression of both CgA and glut2 mRNA transcripts was detected after incubating for several days in culture, suggesting that a commitment toward pancreatic differentiation proceeded with time in culture (Fig. 3C) . However, these responses to glucose were not always consistent in the expressions of CgA and glut2 in different HAE cell specimens. Augmented expression levels of CgA was much higher than that of glut2 in HAEa cells. In contrast, glut2 was much more sensitive to be induced by higher doses of glucose in HAEb cells. Differential levels of the induced mRNA of CgA and glut2 by high concentrations of glucose (35mM) were detected in these two different specimens in culture for a week. -and + indicate concentrations of added glucose as 5mM and 35 mM, respectively, in the presence of nicotinamide(10mM). We also detected amylase gene expression. There are known to be three isozymes specific for salivary, pancreatic and hepatic cell types in humans; the corresponding genes are designated Amy1, Amy2A and Amy2B, respectively [26, 27] . Restriction digestion of PCR products by Hae II and BamH1 discriminated the hepatic type (Amy2B) from the pancreatic type (Amy2A) (Fig. 4A & B) .
Restriction digestion with three restriction enzymes identified distinctive mRNAs for isozymes of the cell-type specific amylases (pancreas, liver, salivary) [26] . The amplified cDNA(#1 and #3) using primers a and c were cleaved by Pst1 and BamH1, but cDNA #2 by using primer b was insensitive to the HaeII digestion. These cleavage patterns of three different cDNA(#1, #2 and #3) of HAE cells by the corresponding restriction enzymes indicate that the same type of amylase isoform ought to be expressing in hepatoma cell line HepG2 but neither pancreas nor salivary. Moreover, since pancreatic cDNAs amplified by all three primers consisted of heterogeneous cDNAs that represent different sensitivities to all three restriction enzymes, implicating that pancreatic amylase may contain different isoforms.
Overall, these results demonstrate that Oct4-positive HAE cells possess differentiation potentials toward various cell types belonging to neuroectodermal and neuroendocrin cells that include nerve cells, pancreatic cells, hepatic cells and biliary ductal epithelial cells.
Origin and the Fate of Oct4-Positive Cell in Amniotic Membrane
Although the fate of Oct4-positive cells within the human amnion is not exactly known, some may detach from the HAE layer and become amniotic fluid cells as found in the amniotic cavity (Fig. 5A . arrow a; arrows b and c indicate Oct4-positive and negative HAE cell, respectively). A few of them may be remained as amniotic fluid cells and can be detectable to be Oct4-positive cells recovered from amniotic fluid (Fig. 5B , right-hand panel, arrow b; arrow a indicates Oct4-positive HAE cell). In addition to these Oct4-expressing cells within the HAE layer, Oct4-positive cells in human amniotic mesoderm were also found, albeit on a discrete level, (Fig. 5C, marking squares a and b) . The magnified figures for the typical area, a and b, clearly showed a solitude Oct4-positive cells in the matrix of amniotic mesoderm (Fig. 5C, right-hand panels a and b, arrows) .
These immunohistochemical observations have directly demonstrated the potentially useful specific cell subsets that express Oct4 at various levels in the HAM throughout gestation.
DISCUSSION
We have demonstrated that HAM contains putatively pluripotent somatic stem cells expressing Oct4-protein.
Oct4-positive cells were identified as cell subsets that differentially expressed Oct4 protein in vivo and in vitro. Oct4 is a well-known transcription factor that is expressed during the cell cleavage stage, which occurs very early during embryonic development; moreover, its expression becomes restricted to the ICM of the blastocyst that develops into pluripotent progenitors of extra-embryonic tissues [4-8, 11, 14] . Oct4 expression is then down-regulated within very early human embryos, and no longer detectable in almost all somatic cells by approximately 8th-9th week of gestation [10, 28] . On the other hand, its expression is maintained at high level in migrating primordial germ cells [3, 7, 8, [12] [13] [14] . Regulation of Oct4 expression is associated with epigenetic modification via altered DNA methylation of the transcriptional promoter of Oct4 [29, 30] . Thereby, Oct4 is believed to be negative in almost all somatic cell lineages with hypermethylation at the transcriptional promoter, except for germ line cells and certain cell lines [31, 32] . Fig. (4) . Hepatic-type differentiation identified by the expression of amylase isozyme mRNAs. A) Cell-type specific transcripts were determined by the restriction digestion of the cDNAs (#1, #2 and #3) amplified with the specific primer sets, respectively, using Pst1, HaeII and BamH1. Each amplified cDNA from mRNAs of HAE cells, pancreas and HepG2 exhibits differential sensitivities to Pst1, HaeII and Bam H1. +, indicates enzyme treatment. B) Schematic illustration for differential cleavage patterns of the amplified cDNA(#1, #2 and #3) using the different set of primers (a, b and c).
In this study, we have identified the Oct4-positive cell subset that resides at a specific location within the HAE layer obtained at full-term gestation. This is the first clear evidence for a resident Oct4-expressing cell mass in extraembryonic tissue from late gestation. While it has not been clarified why HAE cells contain various cell types with a wide spectrum of differentiation, we noted in this study that the expression levels of the Oct4-protein were varied within individual Oct4-positive HAE cells. Since differential levels of Oct4 expression should be critically important for the determination of cell-fate of the pluripotent ES cells [7] [8] [9] , it is likely that various differentiating cell types in the amniotic fluid were possibly derived from Oct4-expressing HAE cells [19, 20] . Our present study may explain, at least in part, the origin of the few Oct4-positive cells that have been found within human amniotic fluid [17] . These observations might allow us to speculate as to what physiological molecules are produced by the wide variety of functional HAE cells present and which play a constructive role in the growth of various tissues and organs during fetal development. Consistently, a number of different cytokines and growth factors have been detected in culture media of HAE cells, as well as in amniotic fluid [33] . As a consequence of these characteristics, HAE cells (or HAM) could be reasonable source of implantation for clinical purposes [25, [34] [35] [36] . As no suitable Since symmetrical cell cleavage occurs in Oct4-positive cells, Oct4-expressing HAE cells appeared to possess selfamplifying potential, implicating that the number of Oct4-positive cells may maintain at constant level during full-term gestation. This speculation could be supported by the observation that Oct4-positive HAE cells were, more or less, capable of maintaining a self-amplifying potential, resulting in the formation of microcolonies consisting of a cohort of Oct4-positive cells. Selective and continued proliferation of these Oct4-expressing HAE cells may supply a unique cell system that could have pluripotent human cell lines alike ES cells, since the expression of a set of genes related to undifferentiated human ES cell lines [22] was detected in HAE cells. However, expression of catalytic subunit of telomerase (hTERT) was not detected by RT-PCR within the cultured HAE cells from any stages of gestation as yet. Since telomerase activity detectable in normal human epithelial cells is dynamically regulated and restricted to a specific cell subset that is undergoing DNA synthesis [24, 37, 38] , not all Oct4-positive HAE cells may have detectable telomerase activity. In fact, only a small portion of Oct4-positive cells is cycling in consistent with the presence of Ki67-positive cycling cells in vitro (refer to Fig. 2, E) , but it may not be sufficient for detecting telomerase activity unless the proliferating Oct4-positive cells are concentrated [24, 37, 38] .
As for the differentiation potentials, we have shown a possibility for hepatic differentiation, as detected by albumin expression at the mRNA and protein levels. Moreover, since the laser confocal microscopic analysis demonstrated that albumin-producing cells were also CK19-positive, our results lead us to conclude that HAE cells may contain hepatic progenitor cells in a biliary epithelial cell lineage [39] . This process appeared to be time-dependent in culture where an albumin+/CK19+ cell subset became detectable after incubation for longer than a week in culture (our unpublished results), suggesting that HAE cells contained stem cells or progenitor cells for the hepatic cell lineage. This is further supported by the detection of hepatic-type amylase gene expression.
We have also detected other neuroendocrine cell markers, such as CgA and glut2, indicating that HAE cells also possess the capacity for differentiation to pancreatic cells [40] . This process also proceeded in a time-dependent manner in culture. These results strongly suggest that a multiple differentiation capacity of HAE cells could be attributable to the presence of the Oct4-expressing cell subset residing in the amnion. However, these cells failed to produce -FP, Insulin and glucagon, possibly due to lack of specific factors in vitro that are necessary for progression towards terminal differentiation. Although the developmental origin of Oct4-positive HAE cells is not precisely known as yet, these may have been derived from ICM (epiblast) but not trophoectodermal origin, as Oct4-positive HAE cells obtained in this study represent phenotypes of neuroendodermal and neuroectodermal cell types. Thus, the fate of Oct4-positive HAE cells could be distinct from that of trophoectodermal stem (TS) cells [10, 41] . Whether Oct4-expressing cell subset could be functionally and genetically equivalent to that of hES cells remains to be investigated.
MATERIALS AND METHODS
Preparation of Human Amniotic Epithelial Cells
Human amniotic specimens used in this study were obtained from approximately 50 cases of full-term, averaged at 40 weeks (40 w), and 5 cases of artificial abortion at 16-18 weeks (16-18 w) gestation that had given informed consent in Hori Maternal Hospital, Yokohama. An ethical committee of Kanagawa Cancer Center inspected and approved the preclinical investigation on amniotic cells prepared from human amniotic apparatus (Sep. 1. 2000) . The amnions were kept at 4 o C in cold HEPES-buffered saline (HBSS) until processing. The amniotic membrane was then mechanically peeled from the associated placental tissues by using a forceps, cut into smaller pieces (approximately 10 x 10 cm 2 in size) and washed several times in HBSS.
The AM fragments were incubated with Dispase solution (Sigma Co., USA) in water bath at room temperature for 30-40 min followed by gentl sonication and swirling under the DM-1 sonic system (DM-1, TOSHO DENNKI, Yokohama, Japan). Clumps of HAE cells were harvested by either precipitation under 1G or a brief centrifugation at 500-800 rpm for a few minutes. The dissociated HAE cells as cell clumps were briefly treated with 0.025% trypsin in 0.01%EDTA solution, if necessary, for the single cell suspension. The mono-dispersed single cell suspension of HAE cells was prepared by filtration through a 100 mm pore size membrane, followed by centrifugation at 1,500 rpm for 5 minutes. This improvement of the cell dissociation method resulted in more efficient and specific recovery of the HAE cells and minimized possible contamination of fibrobrasts, endothelial cells and blood cells.
Cell Culture
The HAE cells were cultured in the following medium as convenient for most human epithelial cells [23, 24] ; a 1:4 (v/v) mixture of Dulbecco's modified Eagle's medium (DMEM) and Ham's MCDB153 medium, respectively, supplemented with hydrocortisone (0.2 mM), epidermal growth factor (EGF) (10 ng/ml), ethanolamine (5 mM), O-phosphoethanolamine (5 mM), transferrin (10 mg/ml), insulin (5 mg/ml), bFGF (10 ng/ml) and bovine pituitary extract (150 mg/ml). HAE cells were plated in collagen IV coated dish.
Immunostaining and Fluorescence Microscopy
The amnion tissue specimens were fixed with 10% formalin overnight and paraffin-embedded samples were prepared by conventional histological methods. Tissue sections of 4 mm thickness were processed for immunohistological examination via the streptoavidin-biotin (SAB) method. Oct4 was detected by mouse monoclonal antibody (clone C10, SC-5279; Santa Cruz Biotechnology; http://www.scbt. com/). Tissue sections were counterstained with hematoxylin. All antibodies used in this study were diluted by phosphate buffered saline (PBS) to an appropriate ratio as indicated in parentheses following each antibody, unless otherwise specified.
As for culture samples for staining nestin and Oct4, the cells were fixed with 10% formalin for 30 minutes and permeabilized with 0.2% Triton X-100 for 5 minutes, followed by incubation in 0.3% H 2 O 2 for 30 minutes. The cells were incubated with a rabbit anti-nestin polyclonal antibody (H-85, SC-20978, Santa Cruz Biotechnology) and a goat antiOct-3/4 polyclonal antibody (1:200) (C-20, SC-8629, Santa Cruz Biotechnology). Immunocytochemistry was performed by the SAB method using the Histofine SAB-PO kit (Nichirei;http://www.nichirei.co.jp / bio / english / index. html). Visualization of antibody-antigen complex was accompl ished using a nickel-intensified 3, 3'-diaminobenzidine reaction (Sigma-Aldrich; http://www.sigmaaldrich.com/Local/ SA_Splash.html).
To carry out double-staining for CK19 and albumin, cultured cells were incubated in PBS for 1 hour, fixed with 4% paraformaldehyde for 10 minutes and permeabilized with 0.2% Triton X-100 for 5 minutes. The slides of fixed cells were then washed three times with PBS-0.2% Tween and blocked with Dako Protein Block Serum Free (DakoCytomation; http://www.dakocytomation-japan.jp/) for 5 minutes. The following primary antibodies, with respective dilutions in parentheses, were used: mouse anti-human CK19 monoclonal (1:100) (Sigma-Aldrich) and sheep anti-human albumin polyclonal (1:50) (Serotic; http://www.serotec.com/asp/ index.html). The respective secondary antibodies used were Cy3-conjugated goat anti-mouse IgG 
RT-PCR and Primers
Total RNA was extracted from cultured HAE cells using TRIZOL (Invitrogen; http://www.invitrogen.com/content. cfm?pageid=13) following the manufacturer's instructions. Target genes were amplified by PCR using the following primer pair combinations ( Table 1 , reference number for primers previously reported were indicated by the number of references). Amplified RT-PCR products were fractionated on Tris-Borate-EDTA 2% agarose gels and visualized under ultraviolet light in the presence of ethidium bromide. ChromograninA : (forward, CCGCTGTCCTGGCTCTTCT; reverse, CCGCTGTGTTTCTTCTGCTG), [25] hCx43 : (forward, TACCATGCGACCAGTGGTGCGCT; reverse, GAATTCTGGTTATCACGGGGAA), [22] hCx45 : (forward, CTATGCAATGCGCTGGAAACAACA; reverse, CCCTGATTTGCTACTGGCAGT), [22] Pro-galanin : (forward, AAGGAAAAACGAGGCTGGAC; reverse, GGACCTGTCAAAGCTTCCTG), [22] Nanog : (forward, AGTCCCAAAGGCAAACAACCCACTTC; reverse, ATCTGCTGGAGGCTGAGG TATTTCTGT CTC), [22] ABCG2 : (forward, GTTTATCCGTGGTGTGTCTGG; reverse, CTGAGCTATAGAGGCCTGGG), [22] hRex1 : (forward, TGAAAGCCCACATCCTAACG; reverse, CAAGCTATCCTCCTGCTTTGG), [22] amylase #1 : (forward, GCTGTGAGTGCAGGAACAAG; reverse, TTGAATTCAGTCACCCGGCC), [26] amylase #2 : (forward, AATTGATCTGGGTGGTGAGC; reverse, CTTATTTGGCGCCATCGATG), [26] amylase #3 : (forward, ACTTGTGGCAATGACTGG; reverse, GAGGATATGCATTTAATTTT), [26] 
